Ryan Preblick

CIK: 0002014866

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (14.3%)

Position reduction

Option Exercises (M)2 (28.6%)

Derivative conversions

Awards (A)2 (28.6%)

Compensation grants

Other (G, F, J, C, D, …)2 (28.6%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

INDV

Indivior Pharmaceuticals, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

INDV
Indivior Pharmaceuticals, Inc.
Jun 8, 2026
Sale(S)
Direct
36K shares at avg. $37.70$1.4M
INDV
Indivior Pharmaceuticals, Inc.
Mar 14, 2026
Exercise(M)
Direct
6.3K shares-
INDV
Indivior Pharmaceuticals, Inc.
Mar 14, 2026
Tax Payment(F)
Direct
2.8K shares at avg. $31.11$88K
INDV
Indivior Pharmaceuticals, Inc.
Mar 3, 2026
Tax Payment(F)
Direct
87.6K shares at avg. $31.98$2.8M
INDV
Indivior Pharmaceuticals, Inc.
Mar 3, 2026
Exercise(M)
Direct
86.9K shares-
INDV
Indivior Pharmaceuticals, Inc.
Feb 10, 2026
Award(A)
Direct
37.4K shares-
INDV
Indivior Pharmaceuticals, Inc.
Feb 9, 2026
Award(A)
Performance Stock Units
Direct
113.5K shares-

		Type	Shares	Price		Ownership
Jun 8, 2026	INDV Indivior Pharmaceuticals, Inc.	Sale(S)	36,000	$37.70	$1,357,200	Direct
Mar 14, 2026	INDV Indivior Pharmaceuticals, Inc.	Exercise(M)	6,302	-	$0	Direct
Mar 14, 2026	INDV Indivior Pharmaceuticals, Inc.	Tax Payment(F)	2,843	$31.11	$88,446	Direct
Mar 3, 2026	INDV Indivior Pharmaceuticals, Inc.	Tax Payment(F)	87,597	$31.98	$2,801,352	Direct
Mar 3, 2026	INDV Indivior Pharmaceuticals, Inc.	Exercise(M)	86,949	-	$0	Direct
Feb 10, 2026	INDV Indivior Pharmaceuticals, Inc.	Award(A)	37,358	-	$0	Direct
Feb 9, 2026	INDV Indivior Pharmaceuticals, Inc.	Award(A) Performance Stock Units	113,510	-	-	Direct

1-7 of 7 transactions

About Preblick Ryan

Preblick Ryan (SEC CIK 0002014866) files insider reports with the SEC as Chief Financial Officer of Indivior Pharmaceuticals, Inc. (INDV).

Signal8 holds 5 ownership filings by Preblick Ryan (1 Form 3, 4 Form 4), filed between Jan 7, 2026 and Jun 10, 2026. Those filings report 7 transactions, from Feb 9, 2026 to Jun 8, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Preblick Ryan's filings is in NORTH CHESTERFIELD, VA.

Recent filings by Preblick Ryan

Jun 8, 2026: Open-market sale of INDV shares (Form 4, code S).
Mar 14, 2026: Option exercise of INDV shares (Form 4, code M).
Mar 14, 2026: Tax withholding of INDV shares (Form 4, code F).
Mar 3, 2026: Tax withholding of INDV shares (Form 4, code F).
Mar 3, 2026: Option exercise of INDV shares (Form 4, code M).

Other insiders filing for Indivior Pharmaceuticals, Inc. (INDV)

Anderson Woodrow D, Chief Accounting Officer
Heidbreder Christian, Chief Scientific Officer
Ciaffoni Joseph, Chief Executive Officer
Thompson Juliet, Director
Humphreys Keith, Director
Kingsley Stuart A, Director

How to read Form 4 transaction codes